Tumeric Acquisition

Four biotechs and a Matthew Roden-led SPAC price IPOs, raising a combined $528M
Endpoints
Fri, 10/16/20 - 12:16 pm
IPOs
biotech
SPAC
Matthew Roden
Praxis Precision Medicines
Tarsus Pharmaceuticals
Aligos Therapeutics
Kiromic Biopharma
Tumeric Acquisition